The Sortina´s mission is to create a platform of life-saving
world-class small molecule therapeutics targeting sortilin.
Focusing on critical diseases such as cancer and
neurodegenerative conditions where sortilin overexpression
or dysfunction has been linked to disease progression.
In-house development of a first in class cancer drug, starting
with Glioblastoma Multiforme, followed by consecutive
inclusion of additional cancer forms and parallel optimization
of unique small molecules for neurodegenerative diseases and beyond.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Erik Dahlbergsgatan 11a, Gothenburg,västra Götaland County 411 26,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.sortinapharma.com
- HQ
- Gothenburg, Västra Götaland County
Sortina Pharma Questions
Sortina Pharma's website is http://www.sortinapharma.com
Sortina Pharma's LinkedIn profile is https://se.linkedin.com/company/sortina-pharma
Sortina Pharma has
4 employees.
View email and phone details for 4
employees at Sortina Pharma.
Sortina Pharma's industry is
Pharmaceutical Manufacturing
Sortina Pharma's top competitors are
Biophenyx,
Ribocure Pharmaceuticals Ab,
Irlab Therapeutics Ab,
Strike Pharma Ab,
Synklino,
Lead Biologics,
Transient Pharma Ab,
Oncorena Ab,
Iscaffpharma,
Mycural Therapeutics.
Sortina Pharma's categories are Pharmaceutical Manufacturing
Sortina Pharma's founding year is 2020
